Review Article
Muscle Invasive Bladder Cancer: From Diagnosis to Survivorship
Table 1
Quality-of-life instruments. (With permission from Lee et al. [44]).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BCI: Bladder Cancer Index; EORTC: European Organization for the Research and Treatment of Cancer. FACIT: The Functional Assessment of Chronic Illness Therapy. FACT-BL: Functional Assessment of Cancer Therapy—Bladder Cancer (Extension of the FACT-G + 12 additional bladder cancer-specific items including incontinence, diarrhea, body image, sexual function, and stoma care). FACT-G: Functional Assessment of Cancer Therapy General. FACT-VCI: Functional Assessment of Cancer Therapy—Vanderbilt Cystectomy Index (Extension of the FACT-G + 17 additional bladder cancer and treatment specific items). QLQ-C30: EORTC Quality-of-Life Core Questionnaire. QLQ-BLM30: EORTC Quality-of-Life Core Questionnaire—Bladder Cancer Muscle Invasive (Extension of the QLQ-C30 + 30 additional bladder cancer-specific items; http://www.eortc.be/home/qol/files/SCManualQLQ-C30.pdf). QLQ-BLS24: EORTC Quality-of-Life Core Questionnaire—Bladder Cancer Superficial (Extension of the QLQ-C30 + 24 additional bladder cancer-specific items; http://www.eortc.be/home/qol/files/SCManualQLQ-C30.pdf). RAND Corporation: Research ANd Development. SF-36: Medical Outcomes Study 36-Item Short Form. |